cardiac amyloidosis, CME education

Join us March 13-15, 2026, for the virtual Masterclass in Cardiac Amyloidosis: Disease Spectrum, Diagnosis and Management.

Led by Program Chair, Saurabh Malhotra, MD, MPH, FASNC, Masterclass features multidisciplinary content that today’s practitioners need to keep current in the rapidly advancing field of cardiac amyloidosis.

Masterclass will cover:

the pathogenesis of cardiac amyloidosis;
diagnostic techniques and pitfalls;
management strategies;
mechanisms to facilitate early diagnosis; and
treatment and management.

The program will feature in-depth sessions led by expert cardiologists, multimodality imagers, hematologists, and neurologists to discuss the disease spectrum, diagnosis, and management of cardiac amyloidosis.

For Technologists: There will be a two-hour session, “Amyloidosis for Technologists: Tips and Tricks from Experts“.

This session is essential for technologists who are or will be performing radionuclide imaging for cardiac amyloidosis. Leading experts will guide you through an overview of the disease, image acquisition and processing and recommendations to avoid potential pitfalls.

This program is offered free of charge.

Register Now

Credits

Earn up to 10* CME/MOC credits.
2* CE credits for the technologist session, Amyloidosis for Technologists: Tips and Tricks from Experts.

Learning Objectives

By the end of the program, you should be able to:

Describe amyloidosis, including specific types, cardiac features, and disease burden.
Identify barriers to identification and diagnosis of patients suspected of ATTR.
Summarize the diagnostic evaluation for cardiac amyloidosis including multimodality imaging and laboratory testing and identify prognostic markers.
Recognize patients at risk for hereditary ATTR (hATTR) and wild-type ATTR (wtATTR).
Explain the importance of genetic testing in hATTR.
Discuss the therapeutic landscape and impact on disease burden.
Define appropriate treatment and management strategies for patients with heart failure.
Formulate strategies for development of a multidisciplinary care team.
Evaluate potential community outreach activities to identify at-risk patients.

Agenda

Friday, March 13				Friday, February 7
5:00 pm	Introduction, Program Goals and Logistics	Saurabh Malhotra, MD, MPH, FASNC
5:05 pm	ASNC’s Role in Amyloidosis Education	Jamieson Bourque, MD, MHS, FASNC
Session 1: Disease and Pathogenesis (Moderator – Saurabh Malhotra, MD, MPH, FASNC)				Saturday, February 8
5:10 pm	Amyloid Fibrils and Amyloidogenesis	Jonathan Wall, PhD
5:40 pm	Amyloidosis: The Changing Clinical Landscape and Evolving Understanding of the Disease	David Wolinsky, MD, MASNC
6:10 pm	Should We Screen for Amyloidosis: When and How Often?	Frederick Ruberg, MD
6:40 pm	Non-Cardiac Manifestations: What to Look For, Where and How?	Wael Jaber, MD, FASNC
7:10 pm	Summary and closing comments	Saurabh Malhotra, MD, MPH, FASNC
Saturday, March 14				Sunday, February 9
10:00 am	Introduction to Day 2	Saurabh Malhotra, MD, MPH, FASNC
Session 2: Diagnostic Techniques and Pitfalls: A Case-Based Discussion (Moderator – David Wolinsky, MD, MASNC)			Session 4: Mediastinum	Timothy Bateman, MD, MASNC; Attila Feher, MD, PhD; and Prashant Nagpal, MD
10:05 am	Multimodality Imaging Strengthens the Suspicion of Amyloidosis	Cesia Gallegos-Kattán MD, MHS FASNC
10:35 am	Nuclear Scintigraphy with Bone Avid Tracers: Improving Study Quality and Interpretation	Saurabh Malhotra, MD, MPH, FASNC
11:05 pm	A Case-Based Journey Through Best Practices and Common Mistakes	Cigdem Akincioglu, MD, FASNC
11:35 am	Novel Tracers and Their Potential Role in Diagnosis and Disease Monitoring	Sharmila Dorbala, MD, MPH, MASNC
12:05 pm	Amyloid Mutations and Role of Genetic Testing	Ashutosh Wechalekar, MBBS, MD
12:35 pm	Final comments	Faculty
	Break
Session 3: Challenges in Diagnosis and Management of ATTR (Moderator – Frederick Ruberg, MD)
1:00 pm	Role of Tissue Diagnosis and Challenges	Angela Dispenzieri, MD
1:45 pm	The More the Merrier? Considerations for Choice of Therapy	Mathew Maurer, MD
2:15 pm	Diagnostic and Treatment Challenges in Underrepresented Populations (age, ethnicity)	Kevin Alexander, MD
2:45 pm	Opportunities and Approach to Starting an Amyloid Program in the Community	Katherine Lee Chuy, MD
3:15 pm	Patient Perspective and Increasing Awareness	Michael LaneAmyloid Patient
3:45 pm	Closing Comments	Saurabh Malhotra, MD, MPH, FASNC
Sunday, March 15
10:00 am	Introduction to Day 3	Saurabh Malhotra, MD, MPH, FASNC
10:05 am	Application of Prognostic Markers in AL and ATTR Amyloidosis	Andrew Staron, MD
10:30 am	Amyloid Polyneuropathy for the Non-Neurologist: Diagnosis and Management	Sasha Zivkovic, MD, PhD
11:00 am	Updates in Management of Heart Failure in Patients with Amyloidosis	Ahmad Masri, MD, MS
11:30 am	Monitoring of Disease: Regression or Progression?	Brett Sperry, MD, FASNC
12:00 pm	Unanswered Questions Across the Spectrum of Care	Prem Soman, MD, PhD, MASNC
12:30 pm	Q&A, final comments, and adjourn	Saurabh Malhotra, MD, MPH, FASNC

Program Chair

Saurabh Malhotra, MD, MPH, FASNC

Amyloidosis for Technologists: Tips and Tricks from Experts

Overview

ASNC will offer a focused 2-hour session for technologists titled, Amyloidosis for Technologists: Tips and Tricks from Experts on Saturday, March 14 from 1-3pm ET. This session is essential for technologists who are or will be performing radionuclide imaging for cardiac amyloidosis. This session will provide an overview of the disease, image acquisition and processing and recommendations to avoid potential pitfalls. Join us for an informative session with leading experts. The session will offer 2* CE credits for technologists.

Objectives

Describe the importance of differentiating amyloid transthyretin cardiac amyloidosis from light-chain amyloidosis
Compare technetium-99m (Tc-99m) HMDP and Tc-99m PYP for diagnosis of cardiac amyloidosis
Summarize key parameters acquisition and processing of Tc-99m bone avid tracers with NaI and CZT camera systems.
Identify artifacts and common pitfalls associated with Tc-99m bone avid tracers for detecting cardiac amyloidosis

Agenda

Saturday, March 14			Friday, February 7
1:00 pm	Welcome and logistics	Sami Abuzaid, MD, EMHL, FASNC and Vasvi Singh, MD, FASNC
1:05 pm	Overview of Cardiac Amyloidosis	Sami Abuzaid, MD, EMHL, FASNC
1:30 pm	Radionuclide Image Acquisition and Processing for ATTR Cardiac Amyloidosis on NaI Systems	Mark Hyun, CNMT, NCT, RS, RT(N,R,CT), FASNC
2:00 pm	Radionuclide Image Acquisition and Processing for ATTR Cardiac Amyloidosis on CZT Systems	Ronald G, Schwartz, MD, MS, MASNC, Maria Mackin, BS MS, CNMT, ARRT(N), FASNC
2:30 pm	Artifacts and Pitfalls, and How to Avoid Them?	Vasvi Singh, MD, FASNC
3:00 pm	Final questions	Faculty